Used in the treatment of prolactin receptor-positive cancers, particularly certain breast and prostate cancers. Targets and blocks the prolactin signaling pathway, which plays a role in tumor growth and cell proliferation. Investigated in clinical trials for its ability to inhibit tumor progression with a favorable safety profile. Also serves as a reference standard in immunoassays and diagnostic development for evaluating anti-PRLR antibody performance.